NCT01422941View on ClinicalTrials.gov

Safety and Performance of the CAVU Medical, Inc. Attune Tubing Study

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

June 30, 2011

Conditions
Obesity
Interventions
DEVICE

CAVU Attune Device

The CAVU Attune device is used with LAGB.

Trial Locations (2)

2154

Institute of Weight Control, Baulkham Hills

2217

St. George Private Hospital, Kogarah

Sponsors

Lead Sponsor

Cavu Medical, Inc.
All Listed Sponsors
lead

Cavu Medical, Inc.

INDUSTRY

NCT01422941 - Safety and Performance of the CAVU Medical, Inc. Attune Tubing Study | Biotech Hunter | Biotech Hunter